Not Yet Recruiting OBSERVATIONAL NCT05895214

Mesopancreas Study in Pancreatic Cancer (MESOPANC-01)

MESOPANC-01 Study: The Mesopancreas and the Ductal Adenocarcinoma of the Pancreatic Head: From Preoperative Imaging to Histopathological and Surgical Outcome

Sponsor: Heinrich-Heine University, Duesseldorf

Conditions Local Recurrent Tumor Margin, Resection PDAC Pancreatoduodenectomy Surgery

Interventions oncological relevance of the mesopancreas

Updated 4 times since 2023 Last updated: May 30, 2023 Started: Jun 1, 2023 Primary completion: Jan 1, 2025 Completion: Jan 1, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Local Recurrent Tumor and Margin, Resection, this trial is actively recruiting participants. The trial is conducted by Heinrich-Heine University, Duesseldorf and has accumulated 4 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Not Yet Recruiting
Sep 2024 — Sep 2025 [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Jul 2023 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Jun 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Heinrich-Heine University, Duesseldorf

Data source: Heinrich-Heine University, Duesseldorf

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Düsseldorf, Germany